This article presents 21 ''Quality Measures for Congenital and Pediatric Cardiac Surgery'' that were developed and approved by the Society of Thoracic Surgeons (STS) and endorsed by the Congenital Heart Surgeons' Society (CHSS). These Quality Measures are organized according to Donabedian's Triad of Structure, Process, and Outcome. It is hoped that these quality measures can aid in congenital and pediatric cardiac surgical quality assessment and quality improvement initiatives.
Background
Ongoing efforts directed at quality assessment and quality improvement in the field of pediatric and congenital cardiac disease 1-3 coincide with maturation and expansion of registry databases. [4] [5] [6] [7] [8] [9] Analysis of these large repositories of data is fundamental to the assessment of outcomes from congenital and pediatric cardiac surgery at a multi-institutional level. It is apparent that substantial variability in the outcomes of pediatric and congenital cardiac surgery still exists. 10 One aspect of overall quality improvement is the reduction in variability of outcomes across centers, and this improvement may be facilitated by adoption of measures and practices that are efficacious and widely applicable. The development and validation of ''measures of quality'' or ''indicators of quality'' is an essential step in this process and can facilitate the transformation of our outcome databases into platforms to assess and improve quality. These ''quality measures'' or ''quality indicators'' can then become a tool to facilitate multi-institutional quality improvement initiatives. Table 1 . This Task Force proposed a list of ''Quality Measures for Congenital and Pediatric Cardiac Surgery.'' The proposal was developed and approved unanimously by the STS Task Force to develop Quality Measures for Pediatric and Congenital Cardiac Surgery. The proposal was then reviewed and approved by the five STS Committees listed in Table 2 , with final approval by the STS Executive Committee. The original set of ''Quality Measures for Congenital and Pediatric Cardiac Surgery'' that were proposed in 2007 have been updated and refined by members of the ''Task Force to develop Quality Measures for Pediatric and Congenital Cardiac Surgery'' to ensure consistency with the current version of the STS Congenital Heart Surgery Database. 11 The Congenital Heart Surgeons' Society (CHSS), in 2011, under the leadership of CHSS President Erle H. Austin III, MD, established a Committee on Quality Improvement and Outcomes, which has the following duties: (1) to create and facilitate multi-institutional initiatives to assess and improve the quality of care delivered to patients with congenital and pediatric heart disease, (2) to establish and maintain a CHSSbased resource for the evaluation of programmatic quality for programs caring for patients with congenital and pediatric congenital heart disease, and (3) to oversee the relationship and linkage of the CHSS to other databases in order to achieve the above objectives and simultaneously further the research mission of the CHSS.
Quality Measures for Pediatric and Congenital Cardiac Surgery
In 2011, the CHSS endorsed the most recent version of the Quality Measures for Congenital and Pediatric Cardiac Surgery that were developed and approved by STS. These Quality Measures for Congenital and Pediatric Cardiac Surgery were unanimously endorsed by the two CHSS Committees listed in Table 2 .
The Quality Measures for Congenital and Pediatric Cardiac Surgery that were developed and approved by STS and endorsed by CHSS are listed in Table 3 and described in detail in Table 4 . Consensus definitions of the morbidities described in Tables 3 and 4 are provided in Table 5 . 5, 11 Discussion At the present time, the evidence supporting the individual Quality Measures for Congenital and Pediatric Cardiac Surgery that are presented in Tables 3 and 4 ranges from consensus of the opinion of experts to published data from analysis of large multi-institutional data sets. 12 Additional data to support these proposed quality measures will be gathered by the STS Congenital Heart Surgery Database. A Quality Module of the STS Congenital Heart Surgery Database is currently under development in order to achieve this objective.
These Quality Measures are harmonized with several ongoing congenital and pediatric cardiac surgical quality and outcomes initiatives. Cardiac Surgery are harmonized with ongoing analyses performed with the STS Congenital Heart Surgery Database that examine ''Failure to Rescue,'' which is the concept of measuring survival versus nonsurvival following complications as a potential measure of performance. [15] [16] [17] Efforts are already underway to gather data to assess these quality measures in the following domains: reliability, validity, importance, scientific acceptability, usability, and feasibility. Questions to be answered include a determination of the relationship of structure measures and process measures to outcome, the assessment as to whether this relationship is one of ''cause and effect'' or simply ''association,'' and an analysis of possible unintended consequences of any of these measures. Eventually, efforts to measure and improve the quality of care of patients with congenital and/or pediatric cardiac disease must also span temporal, geographical, and subspecialty boundaries. 2, 9 As such, development of additional measures of quality should include longitudinal follow-up with longitudinal assessment of quality, global collaboration, and multidisciplinary involvement.
Conclusions
This article presents 21 Quality Measures for Congenital and Pediatric Cardiac Surgery that were developed and approved by STS and endorsed by CHSS. These quality measures are organized according to Donabedian's Triad of Structure, Process, and Outcome. It is hoped that these quality measures can aid in congenital and pediatric cardiac surgical quality assessment and quality improvement initiatives.
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The author(s) received no financial support for the research, authorship, and/or publication of this article. Surgical volume for pediatric and congenital heart surgery: total programmatic volume and programmatic volume stratified by the Five STS-EACTS Mortality Categories 5. Surgical volume for eight pediatric and congenital heart benchmark operations 6. Multidisciplinary preoperative planning conference to plan pediatric and congenital heart surgery operations 7. Regularly Scheduled Quality Assurance and Quality Improvement Cardiac Care Conference, to occur no less frequently than once every two months 8. Availability of intraoperative transesophageal echocardiography (TEE) and epicardial echocardiography 9. Timing of antibiotic administration for pediatric and congenital cardiac surgery patients Care Conference, to occur no less frequently than once every two months Occurrence of a regularly scheduled Quality Assurance and Quality Improvement Cardiac Care Conference to discuss care provided to patients who have undergone pediatric and congenital cardiac surgery operations, including reporting and discussion of all major complications and mortalities, and discussion of opportunities for improvement. A ''Quality Assurance and Quality Improvement Conference'' is also known as a "Mortality and Morbidity Conference" (M and M Conference).
Reporting of compliance will be by reporting the date of occurrence. Annual compliance of 100% equals no fewer than six conferences per year. 1. The conventional pre-procedural ''time-out'', which includes identification of patient, operative site, procedure, and history of any allergies.
2.
A pre-procedural briefing (checklist) wherein the surgeon shares with all members of the operating room team the essential elements of the operative plan; including diagnosis, planned procedure, outline of essentials of anesthesia and bypass strategies, antibiotic prophylaxis, availability of blood products, anticipated or planned implants or device applications, and anticipated challenges.
3.
A post-procedural debriefing (checklist) wherein the surgeon succinctly reviews with all members of the operating room team the essential elements of the operative plan, identifying both the successful components and the opportunities for improvement. This debriefing should take place prior to the patient leaving the operating room or its equivalent, and may be followed by a more in-depth dialogue involving team members at a later time. (The actual debriefing in the operating room is intentionally and importantly brief, in recognition of the fact that periods of transition may be times of instability or vulnerability for the patient.) Such new post-operative neurological deficits may or may not be related to a stroke. If the new post-operative neurological deficit is the result of a stroke (that occurs during the time interval beginning at admission to operating room and ending at the time of hospital discharge) and the neurological deficit persists at discharge, then the following two complications should both be selected: 320 ¼ Neurological deficit, Neurological deficit persisting at discharge 420 ¼ Stroke Thus, this complication (320 ¼ Neurological deficit, Neurological deficit persisting at discharge) should be coded in situations where a patient has a stroke (during the time interval beginning at admission to operating room and ending at the time of hospital discharge) and the neurological deficit persists at discharge. This measure does not include a neurologic deficit (which may or may not be related to a stroke) that does not persist at discharge.
(continued) This measure counts all patients who require any additional unplanned cardiac or non-cardiac operation and/or interventional cardiovascular catheterization procedure occurring (1) within 30 days after surgery or intervention in or out of the hospital, or (2) after 30 days during the same hospitalization subsequent to the operation or intervention. A cardiac operation is defined as any operation that is of the Operation Type of ''CPB'' or ''No CPB Cardiovascular''.
The following operations will always be coded as ''Planned Reoperation'': (1) Delayed Sternal Closure, (2) ECMO Decannulation, (3) VAD Decannulation, (4) Removal of Broviac catheter.
The following operations will always be coded as ''Unplanned Reoperation'': (1) (1) within 30 days after surgery or intervention regardless of the date of hospital discharge, or (2) after 30 days during the same hospitalization subsequent to the operation or intervention.
17
Operative/Procedural Unplanned cardiac reoperation during the postoperative or postprocedural time period, exclusive of reoperation for bleeding Any additional unplanned cardiac operation occurring (1) within 30 days after surgery or intervention in or out of the hospital, or (2) after 30 days during the same hospitalization subsequent to the operation or intervention. A cardiac operation is defined as any operation that is of the operation type of ''CPB'' or ''No CPB Cardiovascular''. The following operations will always be coded as ''Planned Reoperation'': (1) Delayed Sternal Closure, (2) ECMO Decannulation, (3) VAD Decannulation, (4) Removal of Broviac catheter. The following operations will always be coded as ''Unplanned Reoperation'': (1) Reoperation for bleeding, (2) Reoperation for infection, (3) Reoperation for hemodynamic instability, (4) Reoperation for initiation of ECMO or VAD, (5) Reoperation for residual or recurrent lesion.
Operative/Procedural Unplanned interventional cardiovascular catheterization procedure during the postoperative or postprocedural time period Any unplanned interventional cardiovascular catheterization procedure occurring (1) within 30 days after surgery or intervention in or out of the hospital, or (2) after 30 days during the same hospitalization subsequent to the operation or intervention.
Operative/Procedural Unplanned non-cardiac reoperation during the postoperative or postprocedural time period Any additional unplanned non-cardiac operation occurring (1) within 30 days after surgery or intervention in or out of the hospital, or (2) after 30 days during the same hospitalization subsequent to the operation or intervention.
